MedTrace Logo

Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases

NCT00029029 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2020-08-12

No results posted yet for this study

Summary

RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells and may help to relieve pain caused by bone metastases.

PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in relieving pain in patients who have bone metastases.

Conditions

Interventions

PROCEDURE

pain therapy

PROCEDURE

radiofrequency ablation

Sponsors & Collaborators

Principal Investigators

  • J. William Charboneau, MD · Mayo Clinic

Study Design

Purpose
SUPPORTIVE_CARE

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-13
Primary Completion
2002-10-24
Completion
2002-10-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00029029 on ClinicalTrials.gov